Palo Alto, CA, United States of America

Jason Bell

USPTO Granted Patents = 8 

Average Co-Inventor Count = 2.6

ph-index = 4

Forward Citations = 158(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Jason Bell - Innovator in Transposon Technology

Introduction

Jason Bell is a prominent inventor based in Palo Alto, CA. He has made significant contributions to the field of biotechnology, particularly in the area of transposon technology. With a total of 8 patents, his work has advanced the understanding and application of genetic engineering.

Latest Patents

Among his latest patents, Jason has developed systems and methods for transposon loading. This invention provides methods, compositions, and systems for loading transposons with nucleic acid molecules, facilitating transposition reactions of cellular nucleic acids. The present invention aims to improve transposon loading and the yield of productive fragments while minimizing potential nucleic acid fragment loss or cross-contamination. Another notable patent focuses on methods and systems to minimize barcode exchange during the preparation of barcoded next-generation sequencing libraries from a single cell. These methods utilize oligonucleotides containing a 3'-terminated blocking group or sequences that prevent amplification or extension.

Career Highlights

Jason has worked with notable companies in the biotechnology sector, including 10x Genomics, Inc. and 10x Genomics, Inc. His innovative approaches have positioned him as a key player in the development of advanced genetic technologies.

Collaborations

Throughout his career, Jason has collaborated with talented individuals such as Francesca Meschi and Geoffrey McDermott. These partnerships have contributed to the success of his projects and the advancement of the field.

Conclusion

Jason Bell's contributions to transposon technology and genetic engineering have made a lasting impact on the industry. His innovative patents and collaborations continue to shape the future of biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…